Cubist Systematic Strategies’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Cubist Systematic Strategies’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30	Closed	–	–	2012
2016 Q1	$0	Sell	30 -16	-35%	-$318	﹤0.01%	2004
2015 Q4	$1K	Sell	46 -217	-83%	-$6.56K	﹤0.01%	1731
2015 Q3	$8K	Buy	+263	New	+$12.6K	﹤0.01%	1812
2015 Q1	–	Sell	-3,663	Closed	-$344K	–	2230
2014 Q4	$344K	Buy	+3,663	New	+$349K	0.02%	1115
2014 Q3	–	Sell	-1,911	Closed	-$172K	–	1981
2014 Q2	$172K	Buy	+1,911	New	+$117K	0.01%	1220

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Cubist Systematic Strategies's PTX Position: Q2 2016 in Review

Cubist Systematic Strategies sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2016, closing a stake of 30 shares.

Cubist Systematic Strategies first reported a position in PTX in Q2 2014 and held it in 5 quarters. The position peaked at $344K in Q4 2014. 56 funds tracked by Wall St. Rank hold PTX as of Q2 2016.

Cubist Systematic Strategies reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
Cubist Systematic Strategies sold 30 Pernix Therapeutics Holdings, Inc. shares in Q2 2016.
Cubist Systematic Strategies first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 5 quarters.
Cubist Systematic Strategies's Pernix Therapeutics Holdings, Inc. position peaked at $344K in Q4 2014.
56 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2016.

Based on Cubist Systematic Strategies's 13F filing for Q2 2016, filed 15 Aug 2016.